USD 9.4
(0.11%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 131.74 Million USD | 0.44% |
2022 | 131.17 Million USD | 0.36% |
2021 | 130.7 Million USD | 4.39% |
2020 | 125.2 Million USD | 67.99% |
2019 | 74.53 Million USD | 2.8% |
2018 | 72.5 Million USD | 0.89% |
2017 | 71.86 Million USD | 371.05% |
2016 | 15.25 Million USD | 5.36% |
2015 | 14.48 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 126.15 Million USD | -3.97% |
2024 Q1 | 131.37 Million USD | -0.28% |
2023 Q4 | 131.74 Million USD | 0.61% |
2023 Q3 | 130.94 Million USD | 0.11% |
2023 Q1 | 130.62 Million USD | -0.42% |
2023 Q2 | 130.79 Million USD | 0.13% |
2023 FY | 131.74 Million USD | 0.44% |
2022 Q3 | 130.35 Million USD | 0.4% |
2022 FY | 131.17 Million USD | 0.36% |
2022 Q1 | 129.26 Million USD | -1.1% |
2022 Q2 | 129.83 Million USD | 0.44% |
2022 Q4 | 131.17 Million USD | 0.63% |
2021 Q3 | 128.65 Million USD | 0.38% |
2021 Q4 | 130.7 Million USD | 1.59% |
2021 FY | 130.7 Million USD | 4.39% |
2021 Q1 | 127.71 Million USD | 2.01% |
2021 Q2 | 128.16 Million USD | 0.35% |
2020 FY | 125.2 Million USD | 67.99% |
2020 Q1 | 106 Million USD | 42.23% |
2020 Q4 | 125.2 Million USD | 17.1% |
2020 Q3 | 106.91 Million USD | 0.67% |
2020 Q2 | 106.2 Million USD | 0.19% |
2019 FY | 74.53 Million USD | 2.8% |
2019 Q1 | 74.19 Million USD | 2.33% |
2019 Q2 | 74.31 Million USD | 0.17% |
2019 Q3 | 75.65 Million USD | 1.8% |
2019 Q4 | 74.53 Million USD | -1.49% |
2018 Q4 | 72.5 Million USD | 0.25% |
2018 FY | 72.5 Million USD | 0.89% |
2018 Q1 | 71.96 Million USD | 0.14% |
2018 Q2 | 72.13 Million USD | 0.24% |
2018 Q3 | 72.31 Million USD | 0.25% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 FY | 71.86 Million USD | 371.05% |
2017 Q4 | 71.86 Million USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | 15.25 Million USD | 5.36% |
2016 Q4 | 15.25 Million USD | 0.0% |
2015 FY | 14.48 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Esperion Therapeutics, Inc. | 540.94 Million USD | 75.645% |
Theratechnologies Inc. | 58.96 Million USD | -123.425% |
Safety Shot Inc | 1.54 Million USD | -8405.566% |
Cosmos Health Inc. | 12.42 Million USD | -960.444% |
Cronos Group Inc. | 2.53 Million USD | -5087.095% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 81.587% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -262.715% |
Organogenesis Holdings Inc. | 119.35 Million USD | -10.388% |
Universe Pharmaceuticals INC | 5.48 Million USD | -2303.102% |
ProPhase Labs, Inc. | 21.38 Million USD | -516.225% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -21569.243% |
Dynavax Technologies Corporation | 256.91 Million USD | 48.719% |
Radius Health, Inc. | 365.31 Million USD | 63.935% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -4876.44% |
Alvotech | 1.07 Billion USD | 87.75% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -19931.625% |
Alpha Teknova, Inc. | 30.45 Million USD | -332.56% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -677.831% |
SCYNEXIS, Inc. | 15.08 Million USD | -773.667% |
Harrow Health, Inc. | 190.5 Million USD | 30.841% |
Biofrontera Inc. | 5.39 Million USD | -2340.248% |
DURECT Corporation | 20.74 Million USD | -535.057% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -217.261% |
ANI Pharmaceuticals, Inc. | 315.32 Million USD | 58.218% |
RedHill Biopharma Ltd. | 1.17 Million USD | -11131.741% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | -33.32% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -614.92% |
SIGA Technologies, Inc. | 1.46 Million USD | -8899.193% |
Lifecore Biomedical, Inc. | 130.36 Million USD | -1.066% |
Shineco, Inc. | 29.65 Million USD | -344.251% |
Phibro Animal Health Corporation | 525.45 Million USD | 74.927% |
Procaps Group S.A. | 285.93 Million USD | 53.923% |
TherapeuticsMD, Inc. | 8 Million USD | -1545.834% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -220190.267% |
Viatris Inc. | 18.12 Billion USD | 99.273% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -19931.625% |
Rockwell Medical, Inc. | 13.43 Million USD | -880.348% |
Incannex Healthcare Limited | 373 Thousand USD | -35221.448% |
Aytu BioPharma, Inc. | 15.12 Million USD | -770.837% |
Tilray Brands, Inc. | 387.31 Million USD | 65.984% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | 80.461% |
PetIQ, Inc. | 468.3 Million USD | 71.867% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | 69.246% |
Journey Medical Corporation | 17.73 Million USD | -643.085% |
Alimera Sciences, Inc. | 67.39 Million USD | -95.476% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -1491.827% |
Assertio Holdings, Inc. | 40.91 Million USD | -222.03% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -12012.69% |
Embecta Corp. | 1.63 Billion USD | 91.959% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -12652.598% |
Procaps Group, S.A. | 285.93 Million USD | 53.923% |
PainReform Ltd. | 86 Thousand USD | -153096.512% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -272.341% |
Hempacco Co., Inc. | 13.72 Million USD | -859.954% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 586.04 Million USD | 77.519% |
Alvotech | 1.07 Billion USD | 87.75% |
Lantheus Holdings, Inc. | 616.94 Million USD | 78.645% |
Kamada Ltd. | 8.74 Million USD | -1405.877% |
Indivior PLC | 281.6 Million USD | 53.214% |
Currenc Group, Inc. | 31.94 Million USD | -312.442% |
Evoke Pharma, Inc. | 5 Million USD | -2534.98% |
Flora Growth Corp. | 3.67 Million USD | -3487.936% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -12652.598% |
Evolus, Inc. | 126.54 Million USD | -4.112% |
HUTCHMED (China) Limited | 86.13 Million USD | -52.964% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 78.874% |
Akanda Corp. | 3.99 Million USD | -3194.721% |